Paper10398261
Revertant mosaicism in human genetic disorders.
Jonkman MF. Am J Med Genet, 1999. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Revertant mosaicism in human genetic disorders. Papers, record 10398261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10398261
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Diseases, Inborn | Major topic |
| Mosaicism | Major topic |
| Mutation | Major topic |
| Adult | |
| Female | |
| Humans | |
| Skin |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38438628 | Tissue mosaicism following stem cell aging: blood as an exemplar. | Nat Aging | 2024 | https://conductscience.org/library/papers/38438628 | PubMed |
| 32468491 | Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer. | Fam Cancer | 2020 | https://conductscience.org/library/papers/32468491 | PubMed |
| 30809233 | Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework. | Front Immunol | 2018 | https://conductscience.org/library/papers/30809233 | PubMed |
| 28168442 | Revertant mosaicism in genodermatoses. | Cell Mol Life Sci | 2017 | https://conductscience.org/library/papers/28168442 | PubMed |
| 27941868 | Mosaicism in health and disease - clones picking up speed. | Nat Rev Genet | 2017 | https://conductscience.org/library/papers/27941868 | PubMed |
| 25513881 | Somatic mosaicism in the human genome. | Genes (Basel) | 2014 | https://conductscience.org/library/papers/25513881 | PubMed |
| 24785414 | Revertant mutation releases confined lethal mutation, opening Pandora's box: a novel genetic pathogenesis. | PLoS Genet | 2014 | https://conductscience.org/library/papers/24785414 | PubMed |
| 24498493 | Clinical and para clinical findings in the children with tyrosinemia referring for liver transplantation. | Int J Prev Med | 2013 | https://conductscience.org/library/papers/24498493 | PubMed |
| 24147053 | Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). | PLoS One | 2013 | https://conductscience.org/library/papers/24147053 | PubMed |
| 21555586 | Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21555586 | PubMed |
| 17875809 | Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1). | Blood | 2008 | https://conductscience.org/library/papers/17875809 | PubMed |
| 17476352 | Cutaneous mosaicism: right before our eyes. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17476352 | PubMed |
| 14605872 | Genetic and clinical mosaicism in a patient with neurofibromatosis type 1. | Hum Genet | 2004 | https://conductscience.org/library/papers/14605872 | PubMed |
| 14569115 | In vivo reversion to normal of inherited mutations in humans. | J Med Genet | 2003 | https://conductscience.org/library/papers/14569115 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10398261
GET https://conductscience.org/api/papers/v1/10398261/authors